20 Years of Being Your Internet HIV/AIDS
Oral Healthcare Resource
     
     
 
 
IAC 2018 News
Updates from Day 4 of AIDS 2018

Criminalising HIV transmission is counterproductive and should stop, experts say
jm | July 26, 2018

Expert consensus statement on the science of HIV in the context of criminal law
JIAS | July 2018

Research Highlights Wrap-up from AIDS 2018 with NIH’s Dr. Carl Dieffenbach
HIV.gov | July 27, 2018

New Kaposi disease in 21 people with 3 years of HIV control in France
22nd International AIDS Conference, Amsterdam, Netherlands, July 23-27, 2018

Civil society under threat: How can HIV advocates resist the impact?

aidsmap | July 26, 2018

Really Rapid Review — International AIDS Conference 2018, Amsterdam

NEJM Journal Watch | July 29, 2018

 
IAC 2018 Research News
‘It’s sobering’: A once-exciting HIV cure strategy fails its test in people
Jon CohenJul. 25, 2018

First Long-term Immune Response Data for Investigational HIV-1 Preventive Vaccine Announced by Johnson & Johnson
Johnson and Johnson | July 24, 2018

Kick-and-kill with vaccines plus vorinostat has no impact on CD4 reservoir
22nd International AIDS Conference, Amsterdam, Netherlands, July 23-27, 2018

Durable control of HIV infection in the absence of antiretroviral therapy Opportunities and obstacles
Anthony Fauci, National Institutes of Health (NIH), United States

Universal test-and-treat improves population viral suppression in rural South Africa
22nd International AIDS Conference, Amsterdam, Netherlands, July 23-27, 2018
     
IAC 2018 Medical News
Mortality 4.5 times higher in Canadian women with HIV than in general population
22nd International AIDS Conference, Amsterdam, Netherlands, July 23-27, 2018
Mortality after ART starts remains higher in women in Americas and Africa than in Europe
22nd International AIDS Conference, Amsterdam, Netherlands, July 23-27, 2018
Half of adults in HIV group have insomnia--fewer than half of them treated
22nd International AIDS Conference, Amsterdam, Netherlands, July 23-27, 2018
Higher depression and anxiety rates with HIV across ART and viral load categories
22nd International AIDS Conference, Amsterdam, Netherlands, July 23-27, 2018
HIV linked to higher risk of heart failure in 425,000-person US comparison
22nd International AIDS Conference, Amsterdam, Netherlands, July 23-27, 2018
Two-fold higher chance of liver steatosis with HIV in big Brazilian study
22nd International AIDS Conference, Amsterdam, Netherlands, July 23-27, 2018
PrEP use rising in US MSM, but rectal STI rate remains stable
22nd International AIDS Conference, Amsterdam, Netherlands, July 23-27, 2018
 
IAC 2018 Prevention News
Q and A - the PARTNER Study: new results from PARTNER 2
Gilead Announces New Data on the Impact of Truvada® (Emtricitabine and Tenofovir Disoproxil Fumarate) for Pre-Exposure Prophylaxis (PrEP) on the Number of HIV Diagnoses in the United States
Businesswire | July 24, 2018

Incidence of HIV-infection in the ANRS Prevenir Study in the Paris Region with Daily or On Demand PrEP with TDF/FTC
IAC 2018 | July 26, 2018

Among 2590 US adolescents using PrEP, 83.5% are girls, 59% on Medicaid
22nd International AIDS Conference, Amsterdam, Netherlands, July 23-27, 2018
Incidence of HIV-infection in the ANRS Prevenir Study in the Paris Region with Daily or On Demand PrEP with TDF/FTC (07/26/18)
     
IAC Medication News
 

Non-Inferior Efficacy of Dolutegravir (DTG) Plus Lamivudine (3TC) vs DTG Plus Tenofovir/Emtricitabine (TDF/FTC) Fixed-Dose Combination in Antiretroviral Treatment-Naive Adults With HIV-1 Infection-Week 48 Results From the GEMINI Studies

22nd International AIDS Conference, Amsterdam, Netherlands, July 23-27, 2018
ViiV Healthcare announces SWORD 100-week data for Juluca (dolutegravir/rilpivirine) at AIDS 2018
ViiV Healthcare | July 24, 2018

Merck Announces Week 96 Data from Pivotal Phase 3 DRIVE-FORWARD Study of Its Investigational HIV Therapy Doravirine
Businesswire | July 24, 2018

Janssen Presents Switch Data for New HIV-1 Treatment SYMTUZA™ (D/C/F/TAF) and Second Study Supporting its Use in a Rapid Initiation Scenario
PR Newswire | July 24, 2018

Dolutegravir/3TC noninferior to DTG/TDF/FTC at 48 weeks in big ART-naive group
22nd International AIDS Conference, Amsterdam, Netherlands, July 23-27, 2018
 
IAC 2018 HIV & Aging News
Rates of kidney and bone disease--and multiple comorbidities--rising in elderly HIV group
22nd International AIDS Conference, Amsterdam, Netherlands, July 23-27, 2018